Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
暂无分享,去创建一个
Xianghuo He | Shenglin Huang | T. Liu | S. Huang | Yingjun Zhao | S. Wu | J. Ding | Y. Zhao | L. Liang | R. Zhan | X. He | Jie Ding | S Huang | S Wu | Tianhui Liu | S. Huang | J Ding | Y Zhao | L Liang | T Liu | R Zhan | X He | Rong Zhan | T. Liu | T. Liu | Linhui Liang
[1] William Ignace Wei,et al. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.
[2] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[3] Xiaoxia Qi,et al. Gene Expression by a MicroRNA Control of Stress-Dependent Cardiac Growth , 2008 .
[4] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[5] Reuven Agami,et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. , 2006, Cell.
[6] R. Aharonov,et al. Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.
[7] A. Nicholson,et al. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis , 2009, Genes, chromosomes & cancer.
[8] D. Iliopoulos,et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.
[9] Christoph Rodak,et al. MirZ: an integrated microRNA expression atlas and target prediction resource , 2009, Nucleic Acids Res..
[10] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[11] G. Dotto,et al. p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Serrano,et al. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. , 2001, Cancer research.
[13] George A Calin,et al. Micro-RNA profiling in kidney and bladder cancers. , 2007, Urologic oncology.
[14] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[15] A. Gartel,et al. Transcriptional regulation of the p21((WAF1/CIP1)) gene. , 1999, Experimental cell research.
[16] J. Cavaille,et al. C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts , 2009, Nucleic acids research.
[17] L. Lim,et al. MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression , 2008, Molecular and Cellular Biology.
[18] Yiliang Zhang,et al. Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes. , 2008, Biochemical and biophysical research communications.
[19] Bob Löwenberg,et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.
[20] Anindya Dutta,et al. p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.
[21] Gabriele Sales,et al. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. , 2009, Blood.
[22] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[23] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.